Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil

Effectiveness and safety of imipenem/clavulanate and linezolid to treat multidrug and extensively drug-resistant tuberculosis at a referral hospital in Brazil

Evidence on effectiveness, safety, and tolerability of imipenem/clavulanate (IC) and linezolid containing regimens to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB) is scarce. The aim of this observational study is to evaluate the therapeutic contribution of IC...

Full description

Bibliographic Details
Main Authors:	M.A. Arbex, E.H. Bonini, G. Kawakame Pirolla, L. DâAmbrosio, R. Centis, G.B. Migliori
Format:	Article
Language:	English
Published:	Elsevier 2016-11-01
Series:	Revista Portuguesa de Pneumologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173511516300707

Similar Items

Rifabutin: Is it useful in the treatment of multidrug-resistant tuberculosis?
by: S. Tiberi, et al.
Published: (2017-12-01)

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.
Published: (2012-02-01)

Tuberculosis: an ancient and evergreen disease
by: G.B. Migliori, et al.
Published: (2011-06-01)

The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
by: Marcos Abdo Arbex, et al.
Published: (2015-12-01)

The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
by: Marcos Abdo Arbex, et al.
Published: (2015-12-01)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
by: Denise Rossato Silva, et al.

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen
by: Maham Farshidpour, et al.
Published: (2013-01-01)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
by: Jian Du, et al.
Published: (2021-05-01)

Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis
by: L Davies Forsman, et al.
Published: (2015-01-01)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
by: Amaylia Oehadian, et al.
Published: (2022-04-01)

Treatment of Ventilator-Associated Gram-Negative Pneumonia with Imipenem-Cilastatin/Amikacin Versus Ticarcillin-Clavulanate/Amikacin
by: Ahmet ELALDI, et al.
Published: (2006-06-01)

Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
by: Yuan Yuan, et al.
Published: (2022-09-01)

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
by: Haoyue Zhang, et al.
Published: (2023-01-01)

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01)

Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
by: Marie Jaspard, et al.
Published: (2020-08-01)

Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
by: Taher Azimi, et al.
Published: (2022-08-01)

Tuberculosis, one disease, many faces
by: G.B. Migliori, et al.
Published: (2016-01-01)

Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China
by: ZhenZhen Zhang, et al.
Published: (2020-06-01)

Role for Linezolid in drug sensitive tuberculosis
by: S. Ramesh Kumar, et al.
Published: (2024-01-01)

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
by: Juan Eduardo Resendiz-Galvan, et al.
Published: (2023-01-01)

Book review: Tuberculosis: The Essentials. Fourth edition
by: G.B. Migliori
Published: (2011-06-01)

Analysis of efficacy and safety of linezolid-based chemotherapeutic regimens for patients with postoperative multidrug-resistant spinal tuberculosis
by: Jie Qiao, et al.
Published: (2022-05-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Intrathecal/Intraventricular Linezolid in Multidrug-Resistant Enterococcus faecalis Ventriculitis
by: Brian F. Lich, et al.
Published: (2016-10-01)

Linezolid-induced ringed sideroblastic anemia and thrombocytopenia in a child with extensively drug-resistant tuberculosis
by: Snigdha Sippy, et al.
Published: (2021-01-01)

Potassium clavulanate
by: Kotaro Fujii, et al.
Published: (2010-08-01)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
by: Cannas A, et al.
Published: (2019-10-01)

Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature
by: Aravind Swaminathan, et al.
Published: (2017-06-01)

Synergism of Linezolid and Rifampin to Combat Multidrug-Resistant Environmental Enterococci Isolates
by: Mobina Noori, et al.
Published: (2022-08-01)

Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?
by: Rosella Centis, et al.
Published: (2017-03-01)

Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India
by: J.A. Tornheim, et al.
Published: (2020-08-01)

Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients
by: Amaylia Oehadian, et al.
Published: (2022-01-01)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021-07-01)

Multidrug- and extensively drug-resistant tuberculosis: an emerging threat
by: O.M. Kon, et al.
Published: (2009-12-01)

The Emergence of Colistin- and Imipenem-Associated Multidrug Resistance in Escherichia coli Isolates from Retail Meat
by: Iweriebor Benson Chuks, et al.
Published: (2022-12-01)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
by: Giovanni Battista Migliori, et al.
Published: (2021-09-01)

Linezolid: a Promising Agent for the Treatment&nbsp;of Multiple and Extensively Drug-Resistant&nbsp;Tuberculosis
by: Dionysia D. Fermeli, et al.
Published: (2020-09-01)

Multidrug-resistant tuberculosis in admitted patients at a tertiary referral hospital of Bangladesh.
by: Sayera Banu, et al.
Published: (2012-01-01)